NOTE: This is based on 11 open tips for Ixico (IXI)
Ixico (IXI)
Latest Quote Price
8.75p
Ixico (IXI)
Price Change (%)
-1.85%
| Latest Bid :
8.50p
|
Latest Ask :
9.00p
|
| High Today :
8.84p
|
Low Today :
8.52p
|
| This Years High :
20.50p
|
This Years Low :
7.25p
|
| Volume :
17,300
|
MKT Cap :
£4.2M
|
| Trading Velocity :
Premium Only
|
Activity Score :
Premium Only
|
| Consensus Score :
Premium Only
|
Momentum Score :
Premium Only
|
Ixico (IXI) Overview
IXICO plc is a United Kingdom-based company that provides specialist data analytics services to the global biopharmaceutical industry. The services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. The outputs from the data analysis are used to enhance patient selection, monitor drug safety, and assess clinical efficacy of the drug under development. It offers a range of services, such as drug development analytics, imaging operations, post-marketing, and post-marketing. It offers end to end services, including trial design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway.
Premium Content
You are missing Premium Content from this chart
Please Log In to a premium account or Sign Up today to view premium content.
Ixico (IXI) Active Short Positions
| Fund Manager |
Position |
Date |
|
No active short positions
|
See more short positions...
| Latest Bid :
8.50p
|
Latest Ask :
9.00p
|
| High Today :
8.84p
|
Low Today :
8.52p
|
| This Years High :
20.50p
|
This Years Low :
7.25p
|
| Volume :
17,300
|
MKT Cap :
£4.2M
|
Ixico Overview
IXICO plc is a United Kingdom-based company that provides specialist data analytics services to the global biopharmaceutical industry. The services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. The outputs from the data analysis are used to enhance patient selection, monitor drug safety, and assess clinical efficacy of the drug under development. It offers a range of services, such as drug development analytics, imaging operations, post-marketing, and post-marketing. It offers end to end services, including trial design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway.
NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Ixico (IXI) Share Price